A patient pays your practice for a GLP-1 or peptide-related program. You evaluate the patient, place an order with a compounding pharmacy, and the pharmacy ships the medication directly to the patient.
Operationally, that arrangement can look simple.
From a payment processor's perspective, it can be much harder to underwrite.
The practice collects the money, but another company may dispense the product. The practice may never physically handle the medication. Delivery can take days or longer, patients may expect the medication immediately, and a delay can quickly turn into a refund request or chargeback.
This dropship model is one reason GLP-1 payment processing has become a significant issue for practices offering weight-management and other peptide-related programs.
As Bart Phelps puts it:
"Compounded GLP-1s are ground zero for this scrutiny right now."
For integrative medicine practices, functional medicine clinics, med spas, DPC practices, naturopathic clinics, and other specialty practices, the important point is not simply that processors are paying closer attention to GLP-1s.
It is that the business model surrounding the medication matters.
Why GLP-1 Payment Processing Has Become More Complicated
GLP-1-based therapies have become a major part of the cash-pay healthcare market. Practices have built programs around patient evaluation, prescribing, ongoing monitoring, lifestyle support, laboratory testing, and medication access.
Some practices use traditional pharmacies. Others work with compounding pharmacies when clinically and legally appropriate.
The payment transaction, however, does not necessarily mirror the clinical workflow. A patient may see a provider through a telehealth appointment, pay the practice for a program, and then receive medication from a separate pharmacy.
That creates several parties in one transaction:
Patient → Practice → Pharmacy → Patient
The processor has to understand where the money goes, what the patient actually purchased, who fulfills the order, and what happens when something goes wrong.
That is much more complicated than:
Patient → Clinic visit → Service delivered → Payment
The distinction is important.
The Dropship Model: Why Processors Have Questions
Consider a common arrangement. A patient enrolls in a weight-management program. The practice evaluates the patient and determines that a GLP-1-related treatment may be appropriate. The patient pays the practice. The practice sends the prescription or order information to a compounding pharmacy, and the pharmacy ships the medication directly to the patient.
The practice never stores or ships the medication. This can create a gap between payment collection and fulfillment.
From the patient's perspective, they paid the practice and are waiting for something to arrive. From the processor's perspective, the merchant accepted the payment but does not control the physical fulfillment process. That creates questions.
Who is responsible for fulfillment?
If the pharmacy is responsible for dispensing and shipping, what happens if the order is delayed?
Who handles the refund?
If the patient wants their money back because the medication has not arrived, does the practice issue the refund?
Who handles a dispute?
If the patient files a chargeback against the practice, can the practice demonstrate what was purchased, what was prescribed, and what was ultimately fulfilled?
What happens if the pharmacy cannot fill the order?
A patient may have paid the practice before the practice knows whether the pharmacy can fulfill the order.
How quickly does the patient receive the product?
The longer the period between payment and fulfillment, the more exposure there can be to cancellations, disputes, and refund requests.
These are payment-processing questions rather than clinical judgments, but they can materially affect how a merchant account is evaluated.
Why Compounded GLP-1s Are Receiving Particular Scrutiny
Compounded GLP-1s sit at the intersection of several issues that payment processors may care about. There is the medical service itself, the medication, the pharmacy relationship, the fulfillment process, possible recurring billing, and substantial patient demand for a product that is not always immediately available.
That combination can create a more complicated merchant profile. A practice might have a perfectly legitimate clinical workflow while still presenting a payment model that a processor considers higher risk.
This distinction is worth emphasizing. Payment-processing risk is not the same thing as clinical risk.
A processor is evaluating its financial exposure. That can include chargebacks, refunds, fulfillment problems, disputes, regulatory concerns, and other factors associated with the merchant's business model.
The Role of Compounding Pharmacies
Practices using compounded medications also need to understand who is responsible for the medication-related portion of the transaction.
A 503A pharmacy and a 503B outsourcing facility operate under different federal regulatory frameworks, and state requirements can also apply. The specific legal and operational arrangement matters.
For a healthcare practice, that means it is important to know exactly what the pharmacy relationship is and what the practice is representing to patients.
The practice should be able to answer questions such as:
- Which pharmacy fulfills the prescription?
- Is the pharmacy appropriately licensed for the services it provides?
- Who dispenses the medication?
- Who ships it?
- Who is responsible for medication-related questions?
- How are prescriptions transmitted?
- What does the patient pay the practice for?
- What does the patient pay the pharmacy for, if anything?
- Who handles refunds?
- What happens when medication is unavailable?
- How are delays communicated?
These questions become particularly important when the practice's website presents medication access as part of a broader program.
503A vs. 503B: Why the Distinction Matters
The terms 503A and 503B refer to different federal categories of compounding pharmacy operations under Section 503 of the Federal Food, Drug, and Cosmetic Act.
At a high level:
503A pharmacies generally compound medications based on prescriptions for identified individual patients, subject to applicable requirements.
503B outsourcing facilities can compound certain medications under a different regulatory framework and are subject to specific federal requirements.
That distinction does not automatically tell a payment processor whether a particular practice is high risk. What matters operationally is the actual arrangement.
A practice should not assume that working with a 503A or 503B pharmacy automatically makes its payment model compliant or processor-friendly. The practice still needs to understand the applicable rules, its contractual relationship with the pharmacy, and what it is representing to patients.
State pharmacy and healthcare laws can also affect the arrangement. For that reason, practices should obtain appropriate legal or regulatory guidance when structuring compounded-medication programs rather than relying on a merchant processor to determine whether the underlying healthcare model is permissible.
Why Delayed Shipping Can Become a Payment Problem
The most important issue in the dropship model may be surprisingly simple:
The patient has already paid.
Suppose a patient pays $500 for a monthly weight-management program that includes clinical management and medication fulfillment. The provider completes the consultation. The prescription is sent to the pharmacy. The pharmacy encounters a supply or fulfillment delay. The patient waits. Then the patient contacts the practice.
From the practice's perspective, the clinical service may have been completed. From the patient's perspective, they paid for a program and still do not have the medication they expected. That disconnect can produce friction.
If the patient requests a refund and the practice refuses because the clinical service was provided, the patient may initiate a chargeback.
A processor sees that dispute differently from the practice. The processor is concerned about whether the merchant can demonstrate that the transaction was valid and that the goods or services associated with it were delivered according to the terms presented to the customer.
This is one reason fulfillment documentation becomes important.
Chargebacks Are More Than a Finance Department Problem
A chargeback can start with a patient who simply says:
"I paid for this and never received it."
For a traditional medical visit, the practice may be able to document the appointment, service date, provider, and payment relatively easily.
For a compounded medication program, the record can involve several steps:
- Patient enrollment
- Clinical evaluation
- Prescription or order
- Pharmacy submission
- Pharmacy acceptance
- Dispensing
- Shipment
- Delivery
- Patient communication
- Ongoing clinical management
If the practice cannot clearly show what happened at each stage, resolving a dispute can become more difficult.
That does not mean every practice needs to build an elaborate fulfillment department. It means the workflow should reflect the actual business model.
What Happens When the Pharmacy Is the Fulfillment Partner?
This is where the dropship model becomes particularly important.
The practice may have excellent clinical documentation but limited visibility into what happens after an order leaves the practice.
For example:
- Was the prescription received?
- Was the order accepted?
- Was the medication available?
- Was it shipped?
- Was it delivered?
- Was the patient notified about a delay?
- Was the order canceled?
- Was a replacement sent?
If the practice cannot answer those questions, it may have difficulty explaining a disputed transaction.
The payment processor does not necessarily care that the practice's clinical documentation was excellent if the dispute concerns a medication the patient says was never received. The financial and clinical workflows need to connect.
Recurring GLP-1 Programs Add Another Layer
Many weight-management practices use recurring memberships or monthly programs. That can be operationally convenient, but recurring billing creates another set of considerations. A patient might authorize a monthly charge while expecting ongoing access to clinical care and medication.
If the patient's prescription changes, the medication becomes unavailable, the patient discontinues treatment, or the patient no longer qualifies for the program, the practice needs a clear process for handling future charges.
Questions to address include:
- When does recurring billing stop?
- Is the medication component included in the membership?
- Is the patient charged if the medication cannot be fulfilled?
- What happens when a provider determines a medication is no longer appropriate?
- How are partial refunds handled?
- How can a patient cancel?
- How are cancellation requests documented?
These are not merely payment questions. They are practice-management questions.
Wellness vs. Medicine: Classification Still Matters
GLP-1 programs also demonstrate why wellness vs. medicine compliance classification should not be treated as a marketing decision.
A practice may use terms such as:
- Weight loss
- Wellness
- Metabolic health
- Medical weight management
- Body optimization
- Hormone health
Those labels can describe very different models.
If a licensed healthcare provider is evaluating a patient, making clinical decisions, prescribing medication, and managing treatment, the practice needs to represent that service accurately. Calling a medical treatment a "wellness product" does not remove the healthcare requirements surrounding the service.
The same principle applies to payment processing. The processor needs an accurate understanding of what the patient is actually purchasing.
Why Marketing Claims Can Affect Underwriting
Payment processors may review websites and other public-facing information as part of merchant underwriting.
That means practice owners should make sure their:
- Website
- Payment pages
- Patient agreements
- Membership terms
- Advertising
- Service descriptions
- Merchant application
tell a consistent story.
A processor that sees a website promoting prescription medication as a guaranteed weight-loss product may have different questions than one reviewing a clearly described medical weight-management service.
The language matters because it helps establish what the merchant is actually selling.
What Practices Should Know About a Compounded Peptides Merchant Account
There is no universal compounded peptides merchant account that every practice can use regardless of its business model.
Processors have their own underwriting standards. A practice looking for payment processing for compounded peptides or GLP-1-related services should expect the processor to want more detail about the arrangement.
Be prepared to explain:
What is being sold?
Is the patient paying for:
- A medical consultation?
- Ongoing medical management?
- A membership?
- Medication?
- A package combining clinical care and medication-related services?
- A broader weight-management program?
Who provides each component?
Identify the provider, practice, and pharmacy roles clearly.
Who fulfills the medication?
Be explicit about whether the practice dispenses the medication or whether a pharmacy fulfills and ships the prescription.
Who collects the money?
This is particularly important if the practice collects a single payment covering multiple components.
What happens if fulfillment fails?
Have a documented process for cancellations, refunds, delays, substitutions where legally and clinically appropriate, and patient communication.
The more clearly these responsibilities are defined, the easier it is to explain the business model during underwriting.
Practical Steps to Reduce Payment-Processing Friction
Practice owners cannot control how a processor ultimately classifies an account. They can, however, make their business model easier to understand.
Map the Money Flow
Write down exactly what happens from the moment a patient schedules until the transaction is fulfilled.
For example:
Patient enrolls → Patient evaluated → Payment collected → Prescription issued → Pharmacy receives order → Medication dispensed → Medication shipped → Patient receives medication
If the practice collects payment before the final steps, identify what happens when one of those steps fails.
Separate Clinical Documentation From Fulfillment Documentation
The clinical record should document the patient's care appropriately. Operational records should also show what happened with the transaction and fulfillment process.
Those are related but not identical.
Review Recurring Billing
If patients are charged monthly, make sure the practice knows:
- What the recurring charge covers
- How patients authorize it
- How patients cancel
- When billing stops
- How refunds are handled
Review Patient-Facing Terms
Patients should understand what they are paying for.
If a payment covers clinical services but medication is fulfilled separately, that relationship should be clearly explained.
Know Your Pharmacy Relationship
Understand exactly which entity is responsible for compounding, dispensing, shipping, and patient medication fulfillment.
Do not assume that the pharmacy's responsibilities automatically become the practice's responsibilities, or vice versa.
Prepare for Processor Questions
A practice applying for a merchant account should be prepared to provide information about:
- Service lines
- Average transaction size
- Monthly volume
- Recurring billing
- Pharmacy relationships
- Fulfillment
- Refund policies
- Chargeback history
- Provider credentials
- Website and marketing
- Business structure
Being prepared can make underwriting conversations much more straightforward.
What Does This Mean for GLP-1 Payment Processing in 2026?
The central issue is not simply that GLP-1s are popular. It is that the market has created business models where medical care, prescription medication, recurring payments, third-party fulfillment, and online transactions can all be part of one patient experience.
That creates more variables for payment processors to evaluate.
The dropship model is a good example. The patient may see one business. The processor sees several relationships:
Patient → Merchant → Provider → Pharmacy → Fulfillment
Every additional handoff creates another place where timing, responsibility, and documentation can become unclear.
That is why compounded GLP-1s have become such a prominent area of payment scrutiny.
The Practical Takeaway for Specialty Practices
If your practice is using compounded GLP-1s or other peptides as part of a patient-care program, do not think about payment processing as simply a matter of finding a company that accepts healthcare merchants.
Start with the actual transaction. Ask: What does the patient pay us for? Then: Who provides each part of what the patient purchased? And finally: What happens after the payment is collected?
Those questions expose the parts of the model that a processor is likely to examine.
A practice that collects payment, provides the clinical evaluation, sends the prescription to a pharmacy, and relies on that pharmacy to ship directly to the patient has a different payment profile from a practice that provides and completes a service entirely within its own clinic.
Neither model is automatically appropriate or inappropriate. They simply create different underwriting questions.
A Final Checklist for GLP-1 Payment Processing
Before approaching a processor, review your program against these questions:
- Is the service accurately described as medical care, wellness, or another applicable category?
- Does the website accurately describe what patients are purchasing?
- Is the role of the prescribing provider clear?
- Is the pharmacy relationship clearly defined?
- Do you know whether the pharmacy is operating as a 503A pharmacy or 503B outsourcing facility, as applicable?
- Is it clear who dispenses the medication?
- Is it clear who ships the medication?
- Does the practice collect payment before fulfillment?
- Are patients clearly informed about fulfillment timelines?
- Are recurring charges clearly authorized?
- Is there a documented cancellation and refund process?
- Can the practice document the clinical service associated with the payment?
- Can staff determine the status of a medication order when a patient calls?
- Can the practice respond to a payment dispute with relevant records?
- Has the merchant account provider reviewed the actual GLP-1 or compounded-medication business model?
The more clearly those questions can be answered, the easier it becomes to explain the business to a payment processor and identify where operational improvements may be needed.
Why the Payment Model Matters as Much as the Service
GLP-1s have changed the way many specialty practices structure patient care, creating new approaches to both clinical services and payment workflows. For practices offering GLP-1-related programs, the payment model is closely connected to how services are scheduled, documented, communicated, and managed.
OptiMantra brings these practice-management workflows together in one platform, helping specialty practices organize the clinical and operational side of GLP-1 programs. Relevant capabilities include:
- Customizable charting: Practices can document patient encounters and create workflows appropriate to their services.
- Electronic prescribing: OptiMantra supports e-prescribing through MDToolbox and Surescripts, including EPCS and controlled-substance workflows where applicable.
- Scheduling: Practices can manage appointments and online booking as part of the broader patient workflow.
- Integrated payments: Payment workflows can be managed within the practice-management environment.
- Patient messaging and portal: Practices can communicate with patients through the patient portal and messaging workflows.
- Lab integrations: OptiMantra supports integrated laboratory workflows, which can be relevant to practices that incorporate laboratory monitoring into patient care.
- Memberships and packages: Practices can manage recurring memberships and prepaid service packages when those models are part of their business.
For practices looking to organize the clinical and operational workflows surrounding these programs, OptiMantra provides EHR and practice management capabilities that bring scheduling, documentation, e-prescribing, patient communication, labs, payments, and related practice workflows together.
Explore an OptiMantra demo or learn more about a free trial to see how the platform can support your specialty practice as your service lines evolve.
Disclaimer: This article is for informational purposes only and is not legal, medical, regulatory, or financial advice. Consult qualified professionals to confirm compliance with applicable laws and requirements.
.png)